Cited by 106Cervical Cancer and HPV ResearchWomen's cancer prevention and managementGlobal Cancer Incidence and Screening

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Vaginal self-sampling is a cost-effective way to increase participation in a cervical cancer screening programme: a randomised trial

Open access

Haguenoer, K, Sengchanh, S, Gaudy-Graffin, C, Boyard, J, Fontenay, R, Marret, H, Goudeau, A, Pigneaux de Laroche, N, Rusch, E, Giraudeau, B·2014·British Journal of Cancer

DOI 10.1038/bjc.2014.510PMC PMC4260034

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Cervical cancer screening coverage remains insufficient in most countries. Our objective was to assess whether in-home vaginal self-sampling with a dry swab for high-risk human papillomavirus (HR-HPV) testing is effective and cost-effective in increasing participation in cervical cancer screening. METHODS: In March 2012, 6000 unscreened women aged 30-65 years, living in a French region covered by a screening programme, who had not responded to an initial invitation to have a Pap smear were equally randomised to three groups: 'no intervention'; 'recall', women received a letter to have a Pap smear; and 'self-sampling', women received a self-sampling kit to return to a centralised virology laboratory for PCR-based HPV testing. RESULTS: Participation was higher in the 'self-sampling' than in the 'no intervention' group (22.5% vs 9.9%, P<0.0001; OR 2.64) and 'recall' group (11.7%, P<0.0001; OR 2.20). In the 'self-sampling' group, 320 used the self-sampling kit; for 44 of these women with positive HR-HPV test results, 40 had the recommended triage Pap smear. The ICER per extra screened woman was 77.8[euro ] and 63.2[euro ] for the 'recall' and 'self-sampling' groups, respectively, relative to the 'no intervention' group. CONCLUSIONS: Offering an in-home, return-mail kit for vaginal self-sampling with a dry swab is more effective and cost-effective than a recall letter in increasing participation in cervical cancer screening.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/bjc.2014.510

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C. D., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,468
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
Hoffmann, T. C., Glasziou, P. P., Boutron, I., Milne, R., Perera, R., Moher, D., Altman, D. G., Barbour, V., Macdonald, H., Johnston, M., et al. (2014) · BMJ · doi:10.1136/bmj.g1687 · Cited by 10,548
Epidemiologic classification of human papillomavirus types associated with cervical cancer
Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. F., & Meijer, C. J. L. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021641 · Cited by 6,249
The 2001 Bethesda System<SUBTITLE>Terminology for Reporting Results of Cervical Cytology</SUBTITLE>
Solomon, D. (2002) · JAMA · doi:10.1001/jama.287.16.2114 · Cited by 3,104
Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration
Boutron, I., Moher, D., Altman, D. G., Schulz, K. F., Ravaud, P., & for the CONSORT Group* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-4-200802190-00008 · Cited by 2,292
Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities
Gakidou, E., Nordhagen, S., & Obermeyer, Z. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050132 · Cited by 976
Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Arbyn, M., Ronco, G., Anttila, A., Meijer, C. J. L. M., Poljak, M., Ogilvie, G., Koliopoulos, G., Naucler, P., Sankaranarayanan, R., & Peto, J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.095 · Cited by 897
The 2001 Bethesda System: Terminology for Reporting Results of Cervical Cytology
Solomon, D., Davey, D. D., Kurman, R. J., Moriarty, A. T., O’Connor, D., Prey, M. U., Raab, S. S., Sherman, M. E., Wilbur, D. C., & Wright, T. (2002) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200208000-00015 · Cited by 822
European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary Document
Arbyn, M., Anttila, A., Jordan, J. A., Ronco, G., Schenck, U., Segnan, N., Wiener, H., Herbert, A., & von Karsa, L. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp471 · Cited by 762
Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis
Arbyn, M., Verdoodt, F., Snijders, P. J. F., Verhoef, V. M. J., Suonio, E., Dillner, L., Minozzi, S., Bellisario, C., Banzi, R., Zhao, F.-H., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70570-9 · Cited by 674
TRENDS IN MORTALITY FROM CERVICAL CANCER IN THE NORDIC COUNTRIES: ASSOCIATION WITH ORGANISED SCREENING PROGRAMMES
Läärä, E., Day, N. E., & Hakama, M. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92695-x · Cited by 662
PHAGOCYTOSIS IN CHRONIC GRANULOMATOUS DISEASE
GAST, G. C. D., Ydema, W., Wiersma, M., & Dankert, J. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92245-x · Cited by 361
Trends of cervical cancer mortality in the member states of the European Union
Arbyn, M., Raifu, A. O., Weiderpass, E., Bray, F., & Anttila, A. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.07.018 · Cited by 298
HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study
Gok, M., Heideman, D. A. M., van Kemenade, F. J., Berkhof, J., Rozendaal, L., Spruyt, J. W. M., Voorhorst, F., Belien, J. A. M., Babovic, M., Snijders, P. J. F., et al. (2010) · BMJ · doi:10.1136/bmj.c1040 · Cited by 293
High‐risk HPV testing on self‐sampled versus clinician‐collected specimens: A review on the clinical accuracy and impact on population attendance in cervical cancer screening
Snijders, P. J. F., Verhoef, V. M. J., Arbyn, M., Ogilvie, G., Minozzi, S., Banzi, R., van Kemenade, F. J., Heideman, D. A. M., & Meijer, C. J. L. M. (2013) · International Journal of Cancer · doi:10.1002/ijc.27790 · Cited by 265
Self-collected HPV Testing Improves Participation in Cervical Cancer Screening: A Systematic Review and Meta-analysis
Racey, C. S., Withrow, D. R., & Gesink, D. (2013) · Canadian Journal of Public Health · doi:10.1007/bf03405681 · Cited by 232
Cost-Effectiveness of Human Papillomavirus DNA Testing for Cervical Cancer Screening in Women Aged 30 Years or More
Goldie, S. J., Kim, J. J., & Wright, T. C. (2004) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000120143.50098.c7 · Cited by 208
HPV self-sampling as an alternative strategy in non-attenders for cervical screening – a randomised controlled trial
Szarewski, A., Cadman, L., Mesher, D., Austin, J., Ashdown-Barr, L., Edwards, R., Lyons, D., Walker, J., Christison, J., Frater, A. P., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.48 · Cited by 175
Human papillomavirus testing on self‐sampled cervicovaginal brushes: An effective alternative to protect nonresponders in cervical screening programs
Bais, A. G., van Kemenade, F. J., Berkhof, J. H., Verheijen, R. H. M., Snijders, P. J. F., Voorhorst, F. J., Babović, M., van Ballegooijen, M., Helmerhorst, T. J. M., & Meijer, C. J. L. M. (2007) · International Journal of Cancer · doi:10.1002/ijc.22484 · Cited by 174
Human papillomavirus in a necessary cause of invasive cervical cancer worldwide
(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140
Self-sample HPV Tests As an Intervention for Nonattendees of Cervical Cancer Screening in Finland: a Randomized Trial
Virtanen, A., Nieminen, P., Luostarinen, T., & Anttila, A. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0307 · Cited by 135
HPV self-sampling or the Pap-smear: A randomized study among cervical screening nonattenders from lower socioeconomic groups in France
Sancho-Garnier, H., Tamalet, C., Halfon, P., Léandri, F.-X., Retraite, L. L., Djoufelkit, K., Heid, P., Davies, P. O., & Piana, L. (2013) · International Journal of Cancer · doi:10.1002/ijc.28283 · Cited by 130
Experience with high‐risk human papillomavirus testing on vaginal brush‐based self‐samples of non‐attendees of the cervical screening program
Gök, M., van Kemenade, F. J., Heideman, D. A. M., Berkhof, J. H., Rozendaal, L., Spruyt, J. W. M., Beliën, J. A. M., Babović, M., Snijders, P. J. F., & Meijer, C. J. L. M. (2011) · International Journal of Cancer · doi:10.1002/ijc.26128 · Cited by 130
Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study
Wikström, I., Lindell, M., Sanner, K., & Wilander, E. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.236 · Cited by 126
The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600)
the Self-Sampling Study Working Group, Giorgi Rossi, P., Marsili, L. M., Camilloni, L., Iossa, A., Lattanzi, A., Sani, C., Di Pierro, C., Grazzini, G., Angeloni, C., et al. (2011) · British Journal of Cancer · doi:10.1038/sj.bjc.6606040 · Cited by 125
Increasing participation in cervical cancer screening: Offering a HPV self‐test to long‐term non‐attendees as part of RACOMIP, a Swedish randomized controlled trial
Broberg, G., Gyrd‐Hansen, D., Jonasson, J. M., Ryd, M., Holtenman, M., Milsom, I., & Strander, B. (2013) · International Journal of Cancer · doi:10.1002/ijc.28545 · Cited by 103
Prevalence of type‐specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self‐collected specimens: Implications for vaginal self‐collection
Belinson, J. L., Hu, S., Niyazi, M., Pretorius, R. G., Wang, H., Chen, W., Smith, J. S., Li, J., Taddeo, F. J., Burchette, R. J., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.25144 · Cited by 86
The potential role of self‐sampling for high‐risk human papillomavirus detection in cervical cancer screening
Schmeink, C. E., Bekkers, R. L. M., Massuger, L. F. A. G., & Melchers, W. J. G. (2011) · Reviews in Medical Virology · doi:10.1002/rmv.686 · Cited by 85
Comparison of use of vaginal HPV self-sampling and offering flexible appointments as strategies to reach long-term non-attending women in organized cervical screening
Darlin, L., Borgfeldt, C., Forslund, O., Hénic, E., Hortlund, M., Dillner, J., & Kannisto, P. (2013) · Journal of Clinical Virology · doi:10.1016/j.jcv.2013.06.029 · Cited by 77
Dry Storage and Transport of a Cervicovaginal Self-Sample by Use of the Evalyn Brush, Providing Reliable Human Papillomavirus Detection Combined with Comfort for Women
van Baars, R., Bosgraaf, R. P., ter Harmsel, B. W. A., Melchers, W. J. G., Quint, W. G. V., & Bekkers, R. L. M. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01506-12 · Cited by 75
Comparison of the SPF 10 -LiPA System to the Hybrid Capture 2 Assay for Detection of Carcinogenic Human Papillomavirus Genotypes among 5,683 Young Women in Guanacaste, Costa Rica
Safaeian, M., Herrero, R., Hildesheim, A., Quint, W. G. V., Freer, E., van Doorn, L., Porras, C., Silva, S., González, P., Bratti, M. C., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02580-06 · Cited by 75
Self‐sampling versus reminder letter: Effects on cervical cancer screening attendance and coverage in Finland
Virtanen, A., Anttila, A., Luostarinen, T., & Nieminen, P. (2010) · International Journal of Cancer · doi:10.1002/ijc.25581 · Cited by 74
Evaluation of Combined General Primer-Mediated PCR Sequencing and Type-Specific PCR Strategies for Determination of Human Papillomavirus Genotypes in Cervical Cell Specimens
Fontaine, V., Mascaux, C., Weyn, C., Bernis, A., Celio, N., Lefèvre, P., Kaufman, L., & Garbar, C. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02098-06 · Cited by 61
Randomized comparison of vaginal self-sampling by standard vs. dry swabs for Human papillomavirus testing
Éperon, I., Vassilakos, P., Navarria, I., Menoud, P.-A., Gauthier, A., Pache, J., Boulvain, M., Untiet, S., & Petignat, P. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-353 · Cited by 39
Dry self-sampling versus provider-sampling of cervicovaginal specimens for human papillomavirus detection in the Inuit population of Nunavik, Quebec
Cerigo, H., Coutlée, F., Franco, E. L., & Brassard, P. (2012) · Journal of Medical Screening · doi:10.1258/jms.2012.012011 · Cited by 36
Testing for human papillomavirus and measurement of viral load of HPV 16 and 18 in self‐collected vaginal swabs of women who do not undergo cervical cytological screening in Southern France
Tamalet, C., Richet, H., Carcopino, X., Henry, M., Retraite, L. L., Heid, P., Léandri, F.-X., Sancho-Garnier, H., & Piana, L. (2010) · Journal of Medical Virology · doi:10.1002/jmv.21835 · Cited by 32
Accuracy of dry vaginal self-sampling for detecting high-risk human papillomavirus infection in cervical cancer screening: A cross-sectional study
Haguenoer, K., Giraudeau, B., Gaudy‐Graffin, C., Pinieux, I. D., Dubois, F., Trignol-Viguier, N., Viguier, J., Marret, H., & Goudeau, A. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.05.026 · Cited by 31
Self-citation
Vaginal self-sampling without preservative for human papillomavirus testing shows good sensitivity
Darlin, L., Borgfeldt, C., Forslund, O., Hénic, E., Dillner, J., & Kannisto, P. (2012) · Journal of Clinical Virology · doi:10.1016/j.jcv.2012.09.002 · Cited by 27
Comparison of HPV genotypes and viral load between different sites of genital tract: The significance for cervical cancer screening
Zhang, S.-K., Ci, P., Velicer, C. M., Kang, L.-N., Liu, B., Cui, J.-F., Chen, F., Zhang, X., Chang, I. J., Roberts, C. C., et al. (2014) · Cancer Epidemiology · doi:10.1016/j.canep.2014.01.004 · Cited by 24
HPV self-testing and cervical cancer screening coverage
Gravitt, P. E., & Rositch, A. F. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70605-3 · Cited by 19
La Haute autorité de Santé (HAS)
Huguier, M., & Rossignol, C. (2013) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)31466-9 · Cited by 14

Flagged first, then by citations

Research works printed but not linked: 1

Duport N, Salines E, Grémy I (2014) [First results of the experimental evaluation of the French organized cervical cancer screening program, 2010–2012]. Bull Epidémiol Hebd 13-14-15: 228–234.

Sorted by citations

Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses
Arbyn, M., Smith, S. B., Temin, S., Sultana, F., & Castle, P. (2018) · BMJ · doi:10.1136/bmj.k4823 · Cited by 851
Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis
Yeh, P. T., Kennedy, C. E., Vuyst, H. D., & Narasimhan, M. (2019) · BMJ Global Health · doi:10.1136/bmjgh-2018-001351 · Cited by 348
Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: A systematic review and meta-analysis of randomised trials
Verdoodt, F., Jentschke, M., Hillemanns, P., Racey, C. S., Snijders, P. J. F., & Arbyn, M. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.07.006 · Cited by 275
Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis
Musa, J., Achenbach, C. J., O’Dwyer, L. C., Evans, C. T., McHugh, M., Hou, L., Simon, M. A., Murphy, R. L., & Jordan, N. (2017) · PLOS ONE · doi:10.1371/journal.pone.0183924 · Cited by 223
Rapid review of evaluation of interventions to improve participation in cancer screening services
Duffy, S. W., Myles, J. P., Maroni, R., & Mohammad, A. (2016) · Journal of Medical Screening · doi:10.1177/0969141316664757 · Cited by 165

See all 106

Authors: Haguenoer, K., Sengchanh, S., Gaudy-Graffin, C., Boyard, J., Fontenay, R., Marret, H., Goudeau, A., Pigneaux de Laroche, N., Rusch, E., & Giraudeau, B.
Affiliations: Inserm (FR)
Centre Hospitalier Universitaire de Tours (FR)
Université de Tours (FR)
Corresponding author: Haguenoer, K
ORCID: Haguenoer, K
Boyard, J
Marret, H
Giraudeau, B
Venue: British Journal of Cancer
Publisher: Springer Science and Business Media LLC
Published: 2014-09-23
Volume: 111
Issue: 11
Pages: 2187-2196
ISSN: 0007-0920 (ISSN-L)
1532-1827
DOI: 10.1038/bjc.2014.510
PMC: PMC4260034
OpenAlex: W2071793902
Cited by: 106
References: 41
Citations by year: 2026: 5 · 2025: 13 · 2024: 12 · 2023: 8 · 2022: 13 · 2021: 4 · 2020: 10 · 2019: 10 · 2018: 9 · 2017: 7 · 2016: 5 · 2015: 9 · 2014: 1
FWCI: 5.56
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-sa
www.springer.com/tdm (unspecified)
Locations: British Journal of Cancer (publishedVersion, cc-by-nc-sa)
Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
PubMed Central (publishedVersion, cc-by-nc-sa)
PubMed (publishedVersion)
HAL (submittedVersion, cc-by-nc-sa)
Funders: Institut National Du Cancer
National Cancer Institute
Topics: Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Keywords: cervical cancer screening, vaginal self-sampling, high-risk human papillomavirus testing, screening uptake, cost-effectiveness, Pap smear, HPV triage
MeSH terms: Adult, Aged, Uterine Cervical Neoplasms, Cost-Benefit Analysis, Female, Follow-Up Studies, Humans, Middle Aged, Patient Participation, Reagent Kits, Diagnostic, Vaginal Smears, Early Detection of Cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Vaginal self-sampling is a cost-effective way to increase participation in a cervical cancer screening programme: a randomised trial

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks